Sentence examples for uncertain trial from inspiring English sources

The victims' survivors would be spared a long and uncertain trial, but in exchange they would have to settle for awards determined by Mr. Feinberg.

Even if a trial does not provide for a cross-over, e.g. because the superiority of the new therapy is still uncertain, trial participants can terminate their trial participation at any time in order to be treated with the new medication (e.g. if it is already approved for another indication) or with similar pharmaceuticals.

First, not surprisingly, partial-error "size" (as assessed by IncSurf and IncDur) increased from undetected to detected trials, with "uncertain" trials being in between.

Conversely, lack of evidence or uncertain clinical trial recommendations may also be associated with changes in clinical practice.

The trial is considered a landmark -- as well as an uncertain test -- of international justice.

However, the clinical consequences of these changes are uncertain and trials of tamoxifen versus placebo in the preventive setting have not indicated differences in cardiac events [ 50].

The effectiveness of this strategy has yet to be tested in a setting related directly to the population's health and it is uncertain whether trials conducted in other areas such as marketing and education can be extrapolated to a health care setting.

Several experienced Guantánamo defense lawyers said the task facing any lawyer who took their cases would be so uncertain that no trial could begin for many months, or years.

But it is still uncertain whether the trial will start on Nov. 12 as planned; lawyers said both the prosecution and the defense were likely to appeal the latest rules about Mr. Kenyatta's attendance.

As they announced the settlements with Tenet and St. Barnabas in June, Justice Department officials said they were satisfied that they had collected a substantial sum of money without risking an uncertain outcome at trial and without endangering the viability of the two hospital systems.

In an editorial published in the New England Journal of Medicine Monday, John Kastelein of Utrecht Medical Center in the Netherlands wrote that it was "uncertain whether the trial will ever reach completion".